- Raised $10M Series B led by Migdal Insurance and Financial Holdings, Jun 2022
- Raised $8M Series A led by Arkin Tech, Jan 2021
- Raised $1.2M Seed Extension led by Arkin Tech, Aug 2020
About
Virility Medical is an Israeli consumer healthcare company that has developed a novel technological solution to treat premature ejaculation. Their flagship product, the in2 patch (also referred to as the Virility Patch or vPatch), is a drug-free, clinically proven, FDA-cleared, and CE-mark approved skin patch based on Electrical Muscle Stimulation (EMS) technology. It is designed to prolong sexual intercourse and enhance men's natural physiological sexual performance by stimulating and contracting pelvic muscles. The company's strategy in the U.S. and Europe focuses on selling the product via online platforms directly to the consumer and to lead drugstores. The in2 Smart device is designed to be discreet, wearable, reusable, and allows users to adjust the intensity to match their needs. It works instantly and does not rely on drugs or numbing agents. Virility Medical's vision is to lead the global shift toward non-pharmaceutical, tech-enabled sexual health, starting with PE and expanding into additional products and solutions—while breaking the silence, normalizing conversations, and enhancing intimacy worldwide.
Funding history · 8 rounds · $19.9M total
Headcount over time
Q&A
- What is Virility Medical's primary product?
- Virility Medical develops the in2 patch, a drug-free, skin patch based on Electrical Muscle Stimulation (EMS) for the treatment of premature ejaculation. It is FDA-cleared and CE-mark approved.
- When was Virility Medical founded?
- Virility Medical was founded in May 2016.
- What is the employee count for Virility Medical?
- Virility Medical has 1-10 employees.
- Which investors participated in Virility Medical's $10 million A Round in July 2022?
- The $10 million A Round in July 2022 included investments from Migdal Insurance and Arkin Group.
- What is Virility Medical's total funding raised to date?
- Virility Medical has raised a total of $21,000,000 USD.
- Who is the CEO of Virility Medical?
- Sharon Ravid is the CEO of Virility Medical.
- What is the company's strategy for selling its product in the U.S. and Europe?
- Virility Medical's strategy in the U.S. and Europe focuses on selling the in2 patch via online platforms directly to consumers and to lead drugstores.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | virilitymedical.com |
|---|---|
| linkedin.com/company/76514990 | |
| facebook.com/Virility-105002841039812 | |
| instagram.com/in2_patch/ |
Identifiers & details
| Legal name | Virility Medical Ltd. |
|---|---|
| Founded | 2016-5 |
| Employees (exact) | 9 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | virilitymedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515448165 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-05-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הנגר 24 הוד השרון |